Vivos Therapeutics (VVOS) Projected to Post Earnings on Thursday

Vivos Therapeutics (NASDAQ:VVOS) is projected to post its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Vivos Therapeutics to post earnings of ($0.43) per share and revenue of $3.89 million for the quarter.

Vivos Therapeutics Stock Performance

Shares of Vivos Therapeutics stock opened at $3.71 on Tuesday. Vivos Therapeutics has a 52 week low of $1.91 and a 52 week high of $6.28. The firm has a fifty day moving average of $3.96 and a two-hundred day moving average of $3.60. The stock has a market capitalization of $21.85 million, a price-to-earnings ratio of -0.65 and a beta of 7.47.

Vivos Therapeutics Company Profile

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.